NCT03756376

Brief Summary

The assessment of renal functional reserve (RFR) has been proposed for the risk stratification of patients undergoing potentially nephrotoxic procedures. The present pilot study is designed to explore the correlation between IRRIV and RFR under pathologic conditions.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2015

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 2, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 13, 2016

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

November 26, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 28, 2018

Completed
Last Updated

November 29, 2018

Status Verified

November 1, 2018

Enrollment Period

2 months

First QC Date

November 26, 2018

Last Update Submit

November 27, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation between IRRIV test and RFR in cardiac surgery patients

    IRRIV test and RFR will be determined and a relationship will be assessed

    Change from baseline to 60 minutes

Secondary Outcomes (1)

  • Concordance between IRRIV test and RFR in cardiac surgery patients

    Change from baseline to 60 minutes

Study Arms (1)

IRRIV and RFR

Enrolled patients will receive IRRIV test and RFR assessment. RFR will be evaluated through a protein loading test. (1.2 g of protein/Kg of body weight) performed with cooked beef. The RFR was then defined as the difference between the highest CrCl obtained after the protein load and the baseline CrCl measured on rest conditions. Concerning the IRRIV test, a weight of 10% of the patient's body weight is applied on the abdominal wall. RRIs is recorded in a middle interlobular artery, every minute for 10 minutes during the echo-renal stress test. The lowest RRI reached is taken as reference (stress RRI). The IRRIV is defined as the percentage difference between baseline RRI and stress RRI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled for cardiac surgery with cardiopulmonary bypass (coronary artery bypass, valve replacements, combined or other operations)

You may qualify if:

  • Estimated GFR (CKD-EPI) greater than or equal to 60 mL/min/1.73 m2
  • Scheduled cardiac surgery with cardiopulmonary bypass (coronary artery bypass, valve replacements, combined or other operations).

You may not qualify if:

  • Age less than 18 years old
  • Pregnancy
  • Ultrasound evidence of morphological kidney abnormalities and/or renal artery stenosis
  • Nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Contrast media in the 2 days before the tests.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Samoni S, Nalesso F, Meola M, Villa G, De Cal M, De Rosa S, Petrucci I, Brendolan A, Rosner MH, Ronco C. Intra-Parenchymal Renal Resistive Index Variation (IRRIV) Describes Renal Functional Reserve (RFR): Pilot Study in Healthy Volunteers. Front Physiol. 2016 Jul 6;7:286. doi: 10.3389/fphys.2016.00286. eCollection 2016.

Related Links

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Claudio Ronco

    Ospedale San Bortolo di Vicenza

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

November 26, 2018

First Posted

November 28, 2018

Study Start

September 2, 2015

Primary Completion

November 10, 2015

Study Completion

January 13, 2016

Last Updated

November 29, 2018

Record last verified: 2018-11